Resilience at Continental Scale

Leveraging Africa and AfCFTA size as a resilience mechanism

Biopharma resilience requires manufacturing facilities in multiple locations across AfCFTA jurisdictions to mitigate risks.

01

Africa’s size of 8,000 km (north to south) by 8,000 km (east to west), one fifth the circumference of the earth, half in Northen and half in Southern hemisphere, multiple polities, >1,000 islands >10 km2, and seven main climatic zones, is an ideal resilience mechanism

02

With Caribbeans coming into AfCFTA, the distance from East African Islands to Jamaica is 15,000 km, ~40% the circumference of the earth

03

Different hubs in the Biotechnopolis are duplicated somewhere in Africa and AfCFTA

04

For each company in the Biotechnopolis there is a twin in one of the remaining AfCFTA jurisdictions

05

All Africans are siblings that are one family and not competitors

06

IMPI partners with different governments to invest in resilience hubs in their own countries